angiotensin II type 1 receptor
Recent Clinical Drug Trials Evidence in Marfan Syndrome and Clinical Implications.
Boston, United States. In Can J Cardiol, Jan 2016
The primary aims of this report were to examine the evidence related to medical therapy for Marfan syndrome, including recently completed randomized clinical trials on the efficacy of β-blockers and angiotensin II receptor blockers for the prophylactic treatment of aortic enlargement in Marfan syndrome, and to provide recommendations for medical therapy on the basis of available evidence.
The role of parvovirus B19 in the pathogenesis of autoimmunity and autoimmune disease.
In J Clin Pathol, Jan 2016
Documented mechanisms in B19-associated autoimmunity include molecular mimicry (IgG antibody to B19 proteins has been shown to cross react with a variety of recognised human autoantigens, including collagen II, keratin, angiotensin II type 1 receptor, myelin basic protein, cardiolipin, and platelet membrane glycoprotein IIb/IIIa), B19-induced apoptosis with presentation of self-antigens to T lymphocytes, and the phospholipase activity of the B19 unique VP1 protein.
[Drug-induced acute kidney injury].
Bern, Switzerland. In Ther Umsch, Dec 2015
NSAIDs, diuretics, ACE inhibitors, and angiotensin II receptor blockers (ARBs} are the most frequent prerenal causes of an acute elevation in creatinine levels.
[Effect of Antihypertensive Drugs on Regression of Left Ventricular Hypertrophy].
In Kardiologiia, 2014
We also demonstrate benefits of the use of fixed combinations of drugs for the treatment of patients with arterial hypertension including those with left ventricular hypertrophy, and stress advantages of angiotensin II receptor blockers characterized by low risk of unfavorable effects and high compliance to treatment over other classes of antihypertensive drugs.